ReaMetrix

NextGen diagnostics — accessible and affordable

Bengaluru, India · Founded 2003 · $6.9M raised

Headquarters
Bengaluru
Employees
11–50
Founded
2003
Business Model
B2B
Total Funding
$6.9M
Last Round
$2.1M Series ANov 2009
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

ReaMetrix is a life science technology and diagnostics company founded in 2003 with operations in Bangalore, India and San Carlos, California. The company develops quality, affordable diagnostic solutions targeting the HIV monitoring and clinical research markets, and was the first Indian company to receive US FDA 510(k) clearance for a dried-down CD4 diagnostic product. ReaMetrix started as a contract research organization serving Western clients and evolved into a medical device innovator focused on making diagnostics accessible in resource-limited settings. The company operates through its Indian subsidiary, ReaMetrix India Pvt. Ltd.

Summary

ReaMetrix is a Healthcare company based in Bengaluru, India, founded in 2003. It has raised $6.9M in total across 3 rounds, most recently a $2.1M Series A round in Nov 2009. Investors include Sequoia Capital, WestBridge Capital and Baring Private Equity.

Funding History

Series ASeries ANov 2009
$2.1M

Sign up to see all 3 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ReaMetrix on Indexed.vc
<a href="https://indexed.vc/companies/reametrix"><img src="https://indexed.vc/api/badge/company/reametrix" alt="ReaMetrix on Indexed.vc" width="260" height="76" /></a>